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Understanding the mechanisms of cardiovascular disease progression is essential is 
developing novel therapies to combat this disease that contributes to 1 in 3 deaths in the 
United States every year. Endothelial dysfunction and its effects on vessel growth and 
remodeling are key factors in the progression and localization of atherosclerosis. Much of 
our understanding in this area has come from in-vivo and in-vitro experiments however 
perfused organ culture systems provide an alternative approach.  Organ culture systems 
can provide a more controlled mechanical, neural, and hormonal environment compared 
to in-vivo models.  This study focused on furthering development of this organ culture 
model by introducing a novel device to produce flow waveforms at the high frequencies 
and low mean flows seen in the mouse model. 
First, a number of designs were considered to allow independent control of the 
amplitude, frequency, shape of the flow waveform.  The ability to independently control 
these parameters results in the independent control of maximum/minimum shear stress 
and shear rate.  The final design incorporated 2 glass syringes driven by a linear motor, 
while the net positive flow was regulated by 2 solenoid pinch valves.  The system was 
monitored by two pressure transducers, transit time ultrasound flow probe, and a camera.  
Each individual mechanism in the system was integrated via a computer using Labview.   
After designing the system it was then thoroughly characterized.  Physiologic, 
physiologic-oscillatory, low, low-oscillatory waveforms and sinusoidal waveforms were 
developed using Matlab to produce code necessary to run the motor.  This 
 x
characterization is not exhaustive but shows the system’s ability to modulate frequency, 
amplitude and waveform independently.  Finally, we were able to incorporate the 
diagnostic capability to measure NO in real-time via and electrical probe.  This probe 
measures changes in current that are proportional to changes in concentration of NO.  
Attempts were made to characterize Reactive Oxygen Species expression as it relates to 
flow but no discernable differences were observed with our current confocal microscopy 
techniques.  Overall this system provides a robust model to test the effects of flow on 





CHAPTER 1:  BACKGROUND 
According the Heart Disease and Stoke Statistics published by the American Heart 
Association an estimated 80,000,000 American adults (approximately 1 in 3) have some 
type of cardiovascular disease (CVD)[1].  CVD accounts for one in 2.8 deaths in the 
United States with total cost on the economy of $475.3 billion [1].  Despite the cost of 
CVD, both in life and monetarily, the progression of the disease in the arterial system is 
still not completely understood.    
 
General Arterial Structure and Function 
Blood vessels play the essential role of transporting nutrients and waste throughout 
the body.  Arteries transport these nutrients to smaller vessels, arterioles, and capillaries, 
which service muscles, organs and other tissues. Arterial walls are heterogeneous soft 
biological tissues composed of endothelial cells, smooth muscle cells (SMC) and 
extracellular matrix (ECM, Figure 1).  The composition of the arterial wall varies 
significantly along the vascular tree and may be characterized as elastic arteries (e.g., 
aorta, common carotid, iliac) or muscular arteries (e.g., coronary, femoral, renal).  
Arterial Structure 
The arterial wall can be divided in three sections, the intima, the media, and the 
adventitia.  The intima, under normal conditions, consists of a single layer of endothelial 
cells adhered to a thin layer of sub endothelial connective tissue called the basal lamina. 
In addition, some arteries (e.g., coronary arteries and aorta) contain a subendothelial layer 
containing collagen and smooth muscle. The internal elastic lamina is a fenestrated sheet 
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of elastin that separates the media from the intima.  The media consists of smooth muscle 
cells (SMC), elastin, collagen, and glycosaminoglycans (GAGs).  The relative amounts of 
SMCs and ECM vary along the vascular tree, with an increasing fraction of SMCs in 
muscular arteries compared to elastic arteries. The adventitia is composed primarily of 
fibroblasts and Type I collagen, with nerves and vaso vasorum in larger vessels.  The 
thicknesses of the intima, media, and adventitia also vary with location along the vascular 
tree; for example, the ratio of media to adventitia thickness in common carotid arteries is 
large compared to that in coronary arteries. A more comprehensive review may be found 
in Rhodin, 1979 and Humphrey, 2002[2]. 
 
Figure 1 - Arterial Layers 
 
Mechanical Environment 
Arteries are exposed to multiaxial mechanical loads, including (a pulsatile) blood 
pressure that causes the vessel to cyclically distend circumferentially, blood flow that 
induces a shearing load along the luminal surface, and an axial extending load; the latter 
is relieved upon excision, causing the vessel to retract. The heart ejects and fills with 
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blood in alternating cycles of systole and diastole, creating a cyclic pumping that results 
in unsteady pulsatile flow and pressure in the arteries [3].  In most cases, blood flow in 
arteries remains forward or zero; however, during diastole, flow rates can become 
reversed in many locations along the vascular tree (i.e. carotid sinus, external carotid, 
brachial, and femoral arteries). In general, the mean pressure and the magnitude of pulse 
pressure decrease with distance away from the heart, with a significant drop in mean and 
pulse pressure across arterioles[3].  
Arteries exhibit a non-linear stress-strain response; they exhibit a visco-elastic 
response, and, they are heterogeneous, orthotropic, and nearly incompressible[2]. Under 
physiological loading arteries experience large deformations, with circumferential and 
axial strains components on the order of 0.3-0.9. Each component of the artery wall plays 
a different role in response to these deformations.  Elastin is more compliant than the 
other components of the media.  It also releases and stores energy over a large range of 
deformations.  Collagen is crimped when unloaded and bears greater mechanical loads as 
the deformations increase.  SMCs come in two forms, contractile and synthetic.   
Synthetic SMCs produce parts of the ECM and Contractile SMCs play an active 
contractile mechanical role.  Normally SMCs are partially contracted giving the vessel a 
basal muscle tone. However stimuli such as altered flow or pressure will cause SMCs to 
contract or dilate. When SMC’s contract they have a larger mechanical contribution in 
the vessel.  This mechanical contribution of the SMC’s with respect to ECM is not 
uniform in all arteries and varies depending on the location along the vascular tree.  
SMCs play a greater mechanical role in muscular arteries that need to constrict and dilate 
often to regulate blood flow to an organ or other tissue[2].  This is true for mesenteric 
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arterioles that regulate blood flow to the intestines and therefore have a high level of 
basal muscle tone. The adventitia plays a mechanical role at high pressures as it is 
thought to reinforce the structural components of the media that lie internally.     
The ratio of collagen, elastin, and GAGs vary depending on the size and location of 
the artery.  In a healthy mature artery there is a homeostasis between cell proliferation 
and cell death, as well as extracellular-matrix synthesis and degradation.  Synthetic SMCs 
play a role in ECM maintenance by producing elastin and collagen while matrix 
metalloproteinase are involved in ECM degradation.  This balance or homeostasis 
maintains healthy arterial structure, geometry, and composition.  However, aging and 
disease can cause changes in the ratio and organization of vascular tissue as well as its 
overall arterial mass.  
Arterial Growth and Remodeling 
Growth, as define by Humphrey[2],” is an increase in mass achieved via an 
increase in the number(e.g. proliferation, hyperplasia, or migration) or size(hypertrophy) 
or cells and/or synthesis of extracellular matrix that exceed degradation”.  Remodeling 
can be defined “as a change in internal structure that is achieved either by reorganizing 
existing constituents or by synthesizing new constituents that have a different 
organization”[2].  Therefore remodeling results in a change in material properties due to 
changes in the mechanical environment.   
The mechanical environment in which an artery lives can be described using both 
global (blood pressure, flow rate, and axial force) and local (circumferential stress, shear 
stress, and axial stress) hemodynamic parameters.   The mechanical environment of cells 
is considered local because circumferential stress, shear stress, and axial stress are felt by 
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cells.  The mechanical environment of vessels is considered global, because pressure, 
flow rate, and axial force act on the vessel as a whole (this sentence is a little confusing).  
This mechanical environment is a key driver of remodeling.  These local and global 
parameters are related to each other using force equilibrium and flow equations below.  
 
Figure 2 - Three basic mechanisms of arterial remodeling 
 
Changes to an artery’s local parameters such as circumferential stress, flow induced 
shear stress, and axial stress alter the homeostasis of the vessel.  To restore natural 
homeostatic levels, the artery remodels itself in a way that maintains stresses felt by the 
cells that make up the vasculature.  The response required differs for each parameter type.  
When pressure increases in the artery, an increase of the artery’s outer radius results and 
while the inner radius remains constant so that the cells can feel their normal mechanical 
environment.  When flow increases, luminal area increases via an increase in the inner 
radius.  Additionally a secondary effect of the luminal diameter increasing is an increase 
in the hoop stress; therefore the vessel wall thickens to return the wall stress to 
homeostatic level.  When sheer stress increases, the endothelial cells up-regulate 
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vasodilators that relax the smooth muscle cells, increasing the diameter of the vessel [4-
6].   The artery is therefore an adaptable organ that changes depending on its mechanical 
environment, always attempting to restore basal level homeostatic values of 
circumferential stress, axial stress, and shear stress.  Although these adaptations are 
meant to protect the vessel in the short term over time these adaptations can manifest 
themselves as disease.   
Wall Shear Stress and Arterial Disease 
An increase in flow rate can cause an artery to dilate via a temporary relaxation of 
the SMCs followed by a long term reconstruction of the media.  The long term 
reconstruction involves the proliferation and migration of SMCs that increases the 
diameter of vessel to restore homeostatic values of shear stress[7].  The opposite is also 
true for a decrease in flow although the mechanism to restore shear stress is different.  At 
first SMCs contract due to the release of vasodilators and endothelium-derived relaxing 
factor (EDRF) by the endothelium.  If the low flow (shear) conditions are chronic the 
process will continue with the vessel mostly thickening in the intima in order to restore 
the shear stress.  Reductions in the release of EDRF or an increase in the concentration of 
vasoconstrictors may be mediators of this process.  If remodeling is not able to change 
the geometry sufficiently to achieve the homeostatic shear stress, continued cell 
proliferation and growth can occur leading to arterial disease. 
Hemodynamic Factors 
While disease states such as high blood pressure can alter an artery’s local 
hemodynamic parameters, the vessel’s geometry itself causes changes in these 
parameters which can lead to arterial disease.  The curvature and branching of the carotid 
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bifurcation causes areas of low and oscillating wall shear stress (and flow). These areas 
show intimal thickening and, subsequently, atherosclerotic plaque formation.  However 
areas of low wall shear coincide with areas of oscillating flow, making it difficult to 
separate correlations between low and oscillatory wall shear stress and intimal thickening 
[8-10].  
Disease Progression 
While these hemodynamic factors appear to localize atherosclerosis, the likelihood 
of progression from intimal thickening to atheroma involves a number of factors.  These 
include, but are not limited to, cholesterol levels, smoking, diabetes, and hypertension.  
These factors increase the likelihood of injury to the endothelial layer of the vessel.  Once 
this occurs dysfunction develops and increases permeability the following cascade of 
events results.   Monocyte adhesion to the endothelium and emigration into the intima 
begin to take place.  Smooth muscles then emigrate from the media to the intima, and the 
monocytes that have permeated the membrane develop into macrophages and then into 
foam cells.  These macrophages and smooth muscle cells engulf lipids that have entered 
the intima in response to the increased permeability.  Smooth muscle cells proliferate in 
the intima and the extracellular matrix begins to reconstitute itself around the lipid debris, 
forming the atherosclerotic plaque[11].  
Biologic Markers 
 
Monocyctes and macrophages play a key role in atherosclerosis.  These cells 
adhere to the endothelium and have specific cell surface binding proteins for the surfaces 
of dysfunctional endothelial cells (EC).  Once bound to the EC the monocytes extravasate 
into the intima where they transform into macrophages and engulf lipids eventually 
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becoming the foam cells which make up the lipid core of atherosclerotic lesions.  
Monocytes are originally attracted by MCP-1(Monocyte Chemo attractant Protein-1) and 
their rolling and adhesions to the vessel wall are modulated by E-selectin and VCAM-1 
(Vascular Cell Adhesion Molecule-1).  Once located within the intima, macrophages 
produce a number of products including additional MCP-1, which recruits more 
monocytes to the area, TNFα(tumor necrosis factor alpha), which further induces the 
inflammatory response,  IL-1(interleukin-1), which increases the expression of adhesion 
factors on endothelial cells, and the production of reactive oxygen species (ROS) such as 
superoxide and hydrogen peroxide.  These ROS mediate the inflammatory response 
through up regulation of pro-inflammatory genes.  Several enzymatic reactions produce 
these ROS, but the most common source is NADPH Oxidase.  The majority of ROS 
produced in vessels walls are produced in smooth muscle cells and fibroblasts[12]. 
 Under normal conditions Nitric Oxide(NO) is an important atheroprotective 
molecule. Vascular NO dilates blood vessels by stimulating guanylyl cyclase and 
increasing cyclic guanosine monophosphate (cGMP) in smooth muscle cells.  NO release 
in the lumen inhibits platelet aggregation and adhesions as well as leukocyte adhesions.  
Since white blood cell adhesion is one of the critical events in the onset atherogenesis, 
this may be a mechanism of NO’s atheroprotective nature.  Additionally, NO has been 
shown to inhibit the proliferations of smoothe muscle cells, a later step in 
atherogenesis[13]. 
 Most vascular production of NO is due to endothelial NO synthase (eNOS) .  In 
its normal state eNOS oxidizes its substrate l-arginine to l-citruline and NO.   This 
functionality requires dimerization of the enzyme,  the substrate of L-arginine, and an 
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important cofactor (6R)-5,6,7,8-tetrahydro-L-biopterin (BH4). Due to NO’s 
atheroprotective nature, it may appear that an increase in eNOS expression, which would 
therefore lead to an increase in NO production, could decrease the risk of atherochlerosis.  
However, in actuality, cardiovascular risk factors are increased with an increase in eNOS 
expression[13].   
 This is because in the presence of oxidative stress or ROS, NO can become 
atherogenerative.  Most vacsculature produc tion of NO is derived from endothelial NO 
synthase (ENOS).  In its normal state eNOS oxidizes its substrate l-arginine to l-sitruline 
and NO.   In the presence of ROS, in particular superoxide (O2
-), NO reacts with 
peroxynitrite iand the atheroprotective nature of NO decreases.  Additionally eNOS 
begins to make peroxynitrite ( ONOO-)  instead of NO, eventually becoming an enzyme 
that generates solely O2
-.[10]  One of the products of the dismutation of O2
-  is H2O2.   
2O2
− + 2H+ → H2O2 + O2 
H2O2  has been shown to increase eNOS expression through transcription and 
posttranscription mechanisms[14].  However, although there is an upregulation of eNOS,  
it is enzymatically disfuncitonal in the presenece of oxidative stress and begins to 
generate O2
- instead of NO.     
Organ and Tissue Culture Devices 
In-vivo investigations provide conditions that are physiologic but it is difficult to 
monitor precisely and continuously the mechanical environment and remodeling response 
of arteries.  Additionally many factors, including hormonal and metabolic changes, may 
affect smooth muscle cell activity and remodeling.  Organ and tissue culture devices 
provide a unique method to keep the vessel in a well-defined biochemical environment 
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that isolates the vessel from non mechanical factors.  This type of device is ideal for 
determining the effects of the mechanical environment on the organ or tissue.  Because 
remodeling in response to altered flow takes longer that current organ culture devices can 
keep smooth muscle cells viable, most investigations to date have explored growth and 
remodeling in response to changes in pressure. 
Many devices have been developed to both test and/or culture vascular cells and 
tissues.  Arterial cells are subjected to both fluid shear stress due to blood flow and cyclic 
hoop stress due to pulse pressures during the cardiac cycle.  The ideal testing device 
should be able to vary both blood flow and pulse pressure at the physiological 
frequencies and ranges of the vessel tested.   A comprehensive device must also be able 
to independently vary blood flow and pulse pressure under varying disease conditions; 
i.e. high and low blood pressure, oscillatory, low wall, and high wall shear stress.   
Some recent tissue culture systems have developed bioreactors for the tissue 
engineering of vascular grafts.   Abiliez et al. [15]have designed a device to culture 
undifferentiated mouse embryonic stem cells in a three dimensional configuration under 
physiologic pulsatile flow and pressure conditions.  This device incorporates pressure 
transducers before and after the culture chamber, an outlet flow probe, a data acquisition 
system, and a flow probe.  However, this system did not measure flow at the point of 
interest, in this case the culture chamber, nor produce murine physiologic maximum flow 
rates of 2.5 ml/min.  The device was able to produce the pulsatile flow rate and pulse 
pressure at 10 hz;  but the flow profile resembled a sinusoidal waveform rather than the 
1/3 – 2/3 physiologic waveform that has higher shear rates.  
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Gleason et al[16] developed a device that shared many qualities with Abiliez et al’s, 
although it was originally designed for organ culture and biomechanical testing of mouse 
arteries instead of tissue engineering, although most recently it has been used for tissue 
culture….  It produces the physiologic pulse pressures at 10 hz.  Although mean flow can 
be controlled in physiologic of 0-10 ml/min; the shape of the flow waveform cannot be 
controlled to model oscillatory, low wall, and high wall shear stress.  This device can 
measure axial load, pressure, as well as diameter and control axial stretch as well as 
transmural pressure.   
Peng et al[17] created a device which uses a flow pump and linear servo-motor pump 
in series to produce a mean flow-rate and pulse pressure.  A PID controller is used to 
control the mean flow rate and the amplitude and waveform of the pulse pressure.  
However this system is not able to produce physiological flow profiles at low flow rates 
(or low wall shear stress), an important flow condition to study the biomechanical and 
biological response of disease progression in arteries.  Additionally the PID controller 
only acted on pressure data, therefore tuning of the flow waveform was secondary and 
only a result of changes in mean flow rate and pulse pressure.  The waveforms at low and 
high flow rates did not appear to have physiologic shear rates or waveforms.  Particularly, 
at lower flow rates (10ml/min), flow reversal is observed as pulsatility increases although 
this cannot be controlled independently.   
Moore et al’s [18] device decouples the effects of shear stress (flow) and hoop 
stretch (pressure) on endothelial cells seeded on tubes, by fixing the seeded tubes with 
non compliant sleeves to prevent cyclic hoop stretch.  With this setup, four conditions can 
be studied (1) static (no shear stress or hoop stretch) (2) shear stress only (with sleeve) (3) 
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hoop stretch (low flow and no sleeve), (4) shear stress and hoop stretch (normal flow and 
no sleeve).  Although robust in its ability to compare simpler cases of (2) and (3) to the 
static conditions of (1) and complex conditions of (4), the system is not appropriate for 
murine vessel culture because of its inability to produce pulse frequencies of 10 Hz.  
Additionally, disease conditions cannot be studied because the system is unable to 
reverse flow to cause a disturbed flow environment.  
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CHAPTER 2:  OBJECTIVES 
Despite significant advances in the development of cell culture devices there are still 
questions regarding the single contribution of each component of blood flow; mean flow, 
amplitude, and frequency. To do this, a system must produce a variety of flow waveforms 
(physiologic, high, low, oscillatory) at various frequencies up to 10Hz[19].  This type of 
system allows for the study of the contributions of the different harmonics flow (mean 
flow, amplitude, and frequency) on growth and remodeling. Additionally this type of 
system can also be used to determine therapeutic effects of mean flow, amplitude, and 
frequency on vessels in culture.     
The design of comprehensive organ culture device that can produce both physiologic 
and disease state flow waveforms is important for the study of cardiovascular disease in 
the murine model.  The ability to decouple low wall shear stress from oscillatory wall 
shear stress while studying vessels in culture is a good model not only to determine how 
each of these conditions affects the biomechanics of the vessel but also to determine if 
there is a difference in the NO or ROS response under oscillatory, low wall shear stress, 
or both.  Towards this end, we have completed the following specific aims, 
 
Specific Aim 1: Design a device that produces continuous flow at various waveforms 
and     physiologic frequencies for use in mouse vessel culture systems. 
Previous organ and cell culture devices have not been shown the ability to control 
the flow waveform at high frequencies to produce oscillatory, low wall, and high wall 
shear stress [15-18] in mouse vessels.  A number of different designs were considered 
including a simple pulsating valve in series with a compliance chamber.  Eventually an 
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adaptation of the device used in Conway et al [20] was chosen because its performance to 
produce oscillatory flow at 1 Hz had been observed in a parallel plate flow chamber.   A 
detail design followed using a series of three way valves, two syringes mounted on a 
linear motor, and an ultrasound flow meter integrated in LABVIEW 7.0 (National 
Instruments).   
 
Specific Aim 2:  Characterize the device capabilities to produce low wall, high wall, 
oscillatory, and physiologic shear stress in mouse vessels at frequencies of 1, 5, and 
10 Hz.   
Flow was measured using a Doppler ultrasound system mounted over the vessel 
or calibration tubing.  More detailed development of syringe mounts was necessary to get 
identical motion responses between the motor and the syringes driving the fluid.  
Additional tuning of the PID controller of the motor was necessary to achieve the high 
frequency response that produced high wall, low wall, oscillatory, and physiologic shear 
stresses at 10 Hz.  Sine waveforms as well as the 1/3-2/3 physiologic waveforms were 
produced in to study affect of shear rates on cultured vessels.    
Specific Aim 3:  Incorporate diagnostic capability to measure NO in real time and 
quantify levels of ROS in live vessels after culture under various flow waveforms.    
 Vessels were subjected to vasodilators and constrictors after culture to determine 
smooth muscle cell viability after culture with the device.   NO was monitored during 
vessel culture while maintaining frequency but changing the waveform and vice versa.  A 
fluorescent ROS probe was utilized to determine if culturing with this device decreases 
the amount of ROS in the vessel.    
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CHAPTER 3:  METHODS 
A robust drive mechanism and secondary flow loop was designed in order to produce 
a number of different flow waveforms at various frequencies.  This device can be used in 
conjunction with the multiaxial organ culture and biomechanical testing device used in 
Gleason et al[16] or various off the shelf testing vessel testing devices.     
Experimental Set-up 
Design Concept 
Many designs were considered to produce the various flow waveforms at 
frequencies up to 10 Hz.  The first design considered was a single syringe mounted on the 
linear motor with a solenoid valve and vessel downstream and the reservoir upstream 
(Figure 3).  This design most resembles the physiology of the cardiovascular system.  The 
oscillation of the syringe mounted to the linear motor both drives media out through the 
vessel.  During diastole or pull phase media is drawn into the same syringe.  This is 
similar to the biomechanics of the heart pushing blood out during systole and pulling 
blood from the lungs during diastole.  However in this design the motor needs to move 
forward and reverse very small increments at a very high frequency.  Additionally the 
valve needs to open and close at this same frequency and in synchronization with the 
high frequency oscillating movements of the linear motor.  Reading the encoder position 
and engaging the solenoid valves at the in this time frame through LABVIEW proved 
difficult considering each loop in the LABVIEW program took 50 ms to execute while 
the response time of the solenoid valves was 25 ms.  Additionally the production of a 
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custom glass syringe with two ports, one accessing the reservoir and the other to the 
vessel, proved difficult in the glass shop.    
 
Figure 3 - Design 1 integrated a syringe mounted to a computer controlled linear motor and two 
computer controlled solenoid valve.   The syringe would pulse the desired waveform, followed by the 
simultaneous closing of the valve proximal to the vessel and opening of the valve between the syringe 
and reservoir. At this time the syringe would recharge with liquid during the zero flow portion of the 
profile.   Labview was used to control all three, although syncing the two valves and motor 
movements at 10 Hz proved difficult.  
 
Another design considered was peristaltic pump in series with a capacitance 
chamber and a solenoid valve proximal to an organ culture device (figure 4).  The flow 
waveform observed is shown below and presents this design’s modularity with respect to 
frequency.  The system was able to produce a waveform at 10 Hz.  However the system 




Figure 4 - Design 2 incorporated a solenoid valve, pulse dampener, and pump head all proximal to 
the vessel chamber.  The pump was set the desired mean flow rate independently of the computer.  
The valve was computer controlled and opened and closes at frequencies up to 10 Hz.  The silicon 
tubing proximal to the valve served as a capacitance chamber that would enlarge and store liquid 
while the valve until the valve opened.  This capacitance gives the device its capability to deliver a low 
flow pulsatile waveform. 
 
The final design consisted two 1 mL glass syringes (VWR) mounted in opposite 
directions on a linear motor (MX80L, Parker Motion) using CNC machined syringe 
mounts.  The syringes were connected to the vessel culture device (Living Systems) using 
a series of three-way Luer lock valves (Cole Palmer) and Masterflex PharMed L/S-13 
tubing (Cole Palmer).  L/S-13 tubing is relatively rigid, has a small diameter, thick walls 
and was chosen to reduce the capacitance in the system.  This tubing is connected to each 
other and various glassware using luer lock fittings (Cole Palmer). 
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Figure 5 - Final Design integrated the linear motor, transit time ultrasound, camera, two pressure 
transducers, and two valves.  All of these peripheral devices are controlled with the same Labview 
program.   Continuous flow was maintained by the synchronization of the valves; when a syringe is 
drawing liquid the valve is open to the reservoir and when the syringe in pushing the corresponding 
valve in open to the vessel.   
 
As motor moves from right to left the syringe on the right pushes out media with a 
prescribed waveform through the tubing and valve into the Living Systems device.  
During this same time period the syringe on the left pulls fluid from the reservoir into the 
chamber.  When the linear motor reached a designated encoder count both valves switch 
their positions, the right one opens to the reservoir and the left one opens to the vessel, 
and the platform on the linear motor reverses direction but maintain the same waveform.  
The simultaneous switching of both valves and reversing of direction enables continuous 
flow with the commanded waveform.          
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Motor Set-up 
The motor selected (MX80L, Parker Motion) is able to make rapid accurate 
movements but does not have the torque limits of other types of linear drive mechanisms, 
e.g. induction motor with gear head and lead screw.  However our priority requirements 
are small accurate movement and therefore we had to sacrifice maximum torque when 
selected this motor.  We compensated for this by reducing friction in the system.   The 
motor set-up consisted of the motor, motor controller (ACR 9000), motor driver, and 
power supply.   
The motion of the motor was controlled using spline code in which a series of 
time points and X coordinates are uploaded to the motor controller.  Matlab was used to 
produce the lines of spline code that correspond to the flow waveform desired (see 
Appendix 1).  These points are coded into a program that is uploaded to the motor 
controller.  When the program is run the motor moves to the commanded X-coordinate at 
the designated time point K.  An example of this code is show below in figure 6.  Once 
uploaded, to code is run via a Labview program that communicates directly with the 
motor controller.   
 
Figure 6 - Example spline code produced using Matlab and uploaded to motor controller.  K 
represents each time point and X represents the position along that axis of the motor 
 
Using Labview to control the motor instead of the Parker propriety ACRview 
program allows for easy integration of motor information, i.e. encoder position, with the 
k 0.000 x -0.000 
k 0.040 x -0.039 
k 0.080 x -0.000 
k 0.120 x -0.000 
k 0.160 x -0.000 
k 0.200 x -0.079 
k 0.240 x -0.118 
k 0.280 x -0.079 
k 0.320 x -0.079 
k 0.360 x -0.079 
k 0.400 x -0.157 
k 0.440 x -0.196 
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response of other entities in the system, i.e. valve control and flow detection.  In order to 
improve motor performance by decreasing the lagging error over time the spline code 
was slightly modified so that the motor would have programmed stops of 250ms at its 
minimum and maximum x-position.  This allows for the motor regularly home during 
extended culture and in doing so reducing any lagging error that aggregates in the PID 
controller overtime.  Additionally because each loop of the Labview program take at 
minimum 50 ms to execute this assures that any external operations that occur at the 
maximum and minimum x-positions of the motor don’t miss the corresponding encoder 
position.   
      
Drive Mechanism 
The drive mechanism of the system consists of the motor (discussed above), the 
syringe, syringe mounts, and the mounting plate.  The glass 1 ml syringes translated the 
displacement of the motor to displacement of liquid with low levels of friction compared 
to plastic syringes.  Although the air does not penetrate the precision fit of the glass 
syringe’s plunger and chamber over a few draw/inject cycles, this is not true over 1000 
cycles where air bubbles are apparent. 
Four syringe mounts (two for each syringe) were machined on a CNC mill to 
assure precise alignment between the chamber and plunger of both syringes and the linear 
motor driving the motion.  Grooves were milled out of the chamber mounts so that the 
syringe rested at the correct height and along the midline of the mounting plate.  The 
plunger tightening plates were designed to align the plunger along the center line as well 
provide a tight coupling between the motion of the syringe and the displacement of the 
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motor.  The chamber tightening plates were designed to reduce chamber displacement 
along the centerline during the inject/draw cycles of each syringe. 
The mounting plate was designed to integrate the linear motor, syringes, and 
syringe mounts along the same centerline.  This plate was machined out of PVC for easy 
cleaning and provides a mounting surface for attaching the two chamber mounts and the 
linear motor.      
 
Figure 7 - Drive Mechanism 
Flow Loop 
In the confined space of an incubator the layout of tubing is important to maintain 
consistency of flow waveform between groups and reduce compliance in the system.  
Masterflex PharMed PBT L/S-13 tubing was used throughout the system because of its 
relatively large wall thickness.   PBT L/S-13 tubing provided a nice compromise between 
the flexibility and compliance of silicon tubing and the rigidity of PTFE tubing.  Tubing 
was connecting using 1/16” Luer lock fittings throughout the loop. 
 22
Priming the system is important to purge the flow tubing and connections of air.  
This improves the response of flow with regard to the displacement of the syringe by 
making the liquid more incompressible.  Two 10 ml glass syringes connected to the 
three-way valve at on each 1ml syringe is used to first prime the lines that service the 
reservoir.  Secondly the each valve is switched and lines to the living system device are 
primed.   
Valve Control 
Three-way solenoid pinch valves (Cole Parmer EW-98302-40) were used to 
control flow between the syringe, reservoir, and the vessel.  These valves control the flow 
of fluid without coming in direct contact with the fluid which reduces contamination and 
eases sterilization. The tubing is silicone based and has and ID of 1/32”, similar to the ID 
of the rest of the tubing in the flow loop.  The tubing in the valves was shortened in order 
to reduce compliance in the system. 
The same labview program used to control the motor was also used to control the 
valves because there opening and closing of them depends on encoder position.   The 
valves have a fast response time of 25 ms therefore any lag in the system is due to 
computing time in the Labview program used to control the valves.   The Labview loop 
execution time was at least 50 ms and over time could increase to 200 ms, therefore 
programmed 250ms stops at the motors maximum and minimum position assure the 
respective encoder value is satisfied for the valves to open or close.  Additionally the 
digital outputs of the National Instrument DAQ  can only output a maximum of 10 V 
while the valve energizes at 12 VDC.  Therefore the valves must be powered from an 
external power source but controlled via the DAQ and labview.  To regulate the power 
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source a circuit, consisting of transistor and a flywheel diode, was designed and built to 
serve as a switch.  When the transistor is energized with 5 V the gateway opens allowing 
current to flow producing the 12 VDC necessary to activate the solenoid (Figure 8). 
 
Figure 8 - Solenoid Valve Circuit 
    
Flow Detection 
In order to detect flow in the through the carotid artery a Transit Time Doppler 
ultrasound system from Transonic Systems was utilized.  The system consisted of .7PS 
probe with a resolution of .05 ml/min, zero offset of +- .2 ml/min, absolute accuracy of +-
15%, and an ultrasound frequency 9.6 MHz.   A Transonic TS420 Flow Meter Module 
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was used to measure the signal from the probe.  The module has a maximum bandwidth 
of 160 Hz to accurately measure flow dynamics of high frequency heart rates.  
Time Transit Doppler ultrasound sound probe consists of a probe body that houses 
the two ultrasound transducers and fixed acoustic reflector opposite the probe body.  The 
flow meter measures both the upstream transit time and downstream transit time via the 
probe.  To measure the upstream transit time the downstream transducer emits a plane 
ultrasound wave that bounces off the reflector onto the downstream transducer.  To 
measure the downstream transit time the transmitting and receiving functions of the two 
transducers is reversed and the ultrasound sound wave travels in the opposite directions.  
The flowmeter subtracts the upstream and downstream transit times which is then 
integrated to determine volumetric flow rate.   
The difference between the downstream and upstream transit time is calculated by 
the flow meter using wide beam ultrasonic illumination.  One ray of an ultrasonic beam 
undergoes a phase shift in transit time that is proportional to the average velocity of the 
liquid times the path over which the velocity is encountered.  The receiving transducers 
some these velocities; whereas the average velocity multiplied by the vessel’s cross 
sectional area yields volume flow.     
System Characterization 
The system was characterized using with Pebax tubing (.5 mm OD) canulated on 
the living systems device and secured using a silicone based adhesive.  The system was 
set up inside of an incubator at 37 °C with the atmosphere maintained at 5% CO2.  The 
design and flow loop were set-up as show in the previous section.   The reservoir was 
pressurized at 100 mmhg using a flow restricting pressure controller (Alicat Scientific). 
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Frequency 
Physiologic waveform were developed using Matlab then uploaded to the motor 
controller and finally the flow data was then analyzed with Matlab to determine the actual 
flow profile of the liquid through the calibration tubing.  Testing waveforms were 
developed at 1 Hz, 5 Hz, and 10 Hz in order to test the vessel response to changes in 
shear rates when max and mean shear stress remains the same.   
Flow Profile 
In addition to developing waveforms at various frequencies, waveforms were 
developed at different profiles at each frequency (1 Hz, 5 Hz, 10 Hz).  Five different 
waveforms were developed; the physiologic waveform with max flow rates of 
approximately 2.0 ml/min and a mean flow rate of .7 ml/min, the physiologic oscillatory 
waveform with max flow rate of 2.0 ml/min but with an oscillatory component that 
lowered the mean flow rate, the low flow waveform with a max flow rate of 1.0 ml/min, 
and low flow oscillatory waveform with a max flow rate of 1.0 ml/min but with an 
oscillatory component that lowers the mean flow, and a high flow waveform with a max 
flow rate of 3.0 ml/min.      
Biological Measurements 
In order to validate the functionality of the device two different tests were 
performed to characterize the biological changes that occurred in the vessel during 
testing.  Two tests were also performed to determine cell viability, smooth muscle cell, 
and endothelial cell functionality after testing.   
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Surgical Preparation and Aseptic Set-up 
All system components that contact either the vessel or media were sterilized 
using an ethylene oxide sterilizer for 12 hours.  Surgery and system assembly were 
performed in a laminar flow hood.  Mounting of the syringes to the motor mounts were 
performed in the incubator once all flow loop connections were made.  
Wild-type adult make mice (Jackson Laboratories) were anesthetized with sodium 
pentobarbital (100mg/kg IP).  Both carotid arteries were isolated, placed in fresh culture 
media, dissected free of perivascular tissue, and mounted on the cannulae using sterile 7-
0 suture.  The vessel was bathed and perfused with Dulbecco’s Modified Eagle 
medium(P/S Invitrogen, Inc ) antibiotics (1000 units/L of penicillin and 100 g/L of 
streptomycin), and 0% to 20% heat activated bovine serum (HI-FBS, Hyclone).  Usually 
carotid arteries were excised and introduced in the flow environment within 1 hour.   
Functional Testing 
A Methyliazol tetrazolium(MTT) assay was used to determine general cell 
viability after 6 hours of culture under physiologic waveform at 10 Hz. The MTS assay 
measures the activity of the reductase enzyme that reduces MTT to formazan resulting in 
a purple color, and therefore measures the metabolic activity of cells.  Following the 
culture carotid segments were incubated for 1-2 hours in an incubator at 37 °C.  Pictures 
were taken of the entire carotid segment using a digital camera after incubation in the 
MTT was complete. 
Contractile function of the vessel was determined at prescribed time points by 
observing the relative changes in diameter in response to the subsequent administration of 
three agents to the adventitial bath: Phenylephrine (PE) to elicit smooth muscle cell 
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contraction, acetylcholine (Ach) to elicit endothelial-dependent dilation, and sodium 
nitropruside (SNP) to elicit endothelial-independent dilation.   
Nitric Oxide Sensor 
Levels of NO release into the lumen were determined using a 200 µm probe 
(World Precision Instrument) and an Apollo 1000 data acquisition system (World 
Precision Instruments).  The vessels measured NO levels 3 cm distal to the vessel at the 
3-way valve.  NO levels were measures using Data Trax software integrated into the data 
acquisition system.  The probe has a response time of  <5 msec, minimum detection limit 
of .2nM, and a sensitivity of 10 pA/nM.   
NO detection was recorded after immediately after excising the vessel.  The 
vessel was held in a zero flow environment, then subjecting to physiologic flow for 20 
minutes, and finally cessation of flow.     
Reactive Oxygen Species Probe 
The presence of reactive oxygen species was measure using a hydrocyanine3 probe 
developed specifically for the detection of ROS[21].  The HCy3 probe excites at 535 λ 
and emits at 560 λ when using confocal microscopy.  The probe was introduced after 
1mg of hydro-Cy3 probe was diluted in 1 mL of methanol.    Then 500 µl of the HCy3 
methanol stock is further diluted into 100 ml of phosphate buffered saline (PBS).  Then 
the lumen of the vessel was perfused (.7 ml/min) with PBS for 5 min using a Masterflex 
peristaltic pump connected to the living systems device that contains the cannulated 
vessel.  The vessel is then perfused in a similar manner with the HCy3-methanol-PBS 
solution for 10 min at a lower flow rate of .2 ml/min.  Then the vessel is perfused with 
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PBS again for 2 minutes in order to rinse the lumen of any residual probe.  The vessel is 
then perfused with 10% formalin in order to fix the cells.   A positive control vessel was 
Two flow conditions were tested in order to determine the level of ROS expression.  The 
vessel was tested with the probe after a low flow culture (.20 ml/min) and physiologic 
flow culture (.7 ml/min at 10 Hz) after 6 hours.   Images were taken both before 
introduction of the probe and after using Zeiss LSM 540 confocal microscope. 
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CHAPTER 4:  RESULTS AND DISCUSSION 
Experiments were conducted to define the novel device’s ability to produce various 
physiologic and disease waveforms at frequencies from 1 – 10 Hz.  Additionally we 
incorporated a probe to measure NO release during culture was performed and methods 
to introduce an imaging probe for ROS production, which can be imaged via confocal 
microscopy of the vessel while still mounted on the organ culture device. 
System Performance 
Mouse in vivo flow measurements of the carotid artery of an anestitized mouse using 
Doppler ultrasound show a mean flow rate of 1 ml/min.  Minimum flow is measure at .6 
ml/min and max flow is measured at 2 ml/min. 
 
Figure 9 - Mouse physiologic flow measure with Transit Time Ultrasound probe.  Note the lower 





At 1 Hz the system was able to produce physiologic, high flow, low-oscillatory, 
low, and sinusoidal waveforms at a steady pressure of 100mmhg.  Also not that all graphs 
at 1 Hz do not include a +2 ml/min offset due zero flow calibration that was not 
performed.  This offset is included for the graphs at 5 Hz and 10 Hz.     
 
Figure 10 – Physiologic waveform at 1 Hz and flow profile of [4, -2, 0, 0, 0] 
Note the max flow of 2.12 ml/min, the minimum flow of 0.18 ml/min, and mean flow of 
.62 ml/min.  These values include a +2 ml/min offset.   Although this physiologic mean 
flow is lower than the mean flow observed in the mouse this is often the benchmark mean 
flow rate for culturing murine carotid arteries[22] 
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Figure 11 – Low Flow waveform at 1 Hz with flow profile of [2, -1, -0.1, 0] 
The low flow waveform has a max flow of 1.05 ml/min, a minimum flow of -.07 ml/min, 
and a mean flow of .26 ml/min.  Note the mean and max flow are half of the 
corresponding physiologic measurements.   
 
Figure 12 –Low flow oscillatory waveform at 1 Hz with profile [2.8, -2, -0.1, -0.1, 0] 
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The low-oscillatory waveform has similar properties to the low flow waveform but note 
the minimum flow of -.01 ml/min and the distinct oscillatory component that indicates 
reverse flow and also lowers the mean flow to .22 ml/min.   
 
Figure 13 – High flow waveform at 1 Hz with profile [12, -3, -0.1, 0, 0, 0, 0, 0, 0, 0] 
The high flow waveform has a maximum flow of 3.1 ml/min, a minimum flow of -.16 
ml/min, and mean flow of 1.0 ml/min.  The high flow not only results in higher shear 
stresses but also higher shear rates. 
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Figure 14 - Sinusoidal waveform at 1 Hz with profile [3.75, -0.1, -0.1, 0] 
The sinusoidal waveform has similar maximum and minimum flows compared to the 
physiologic waveform.  Not the lower flow rates and that result in lower shear rates due 




At 5 Hz the system was able to produce physiologic, physiologic-oscillatory, high flow, 
low-oscillatory, low, and sinusoidal waveforms at a steady pressure of 100mmhg.  Note 
at all 5 Hz profiles have higher flow rates because of the shorter time course for each 
pulse.  This results in higher flow rates and the resulting higher shear rates. 
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Figure 15 - Physiologic waveform at 5 Hz with profile [9.5, -5, -.1, 0, 0] 
Note the max flow of 1.9 ml/min, the minimum flow of .01 ml/min, and mean flow of .86 
ml/min.  Although this physiologic mean flow is lower than the mean flow observed in 
the mouse this is often the benchmark mean flow rate for culturing murine carotid arteries 
 
Figure 16 - Physiologic-oscillatory waveform at 5 Hz with profile [15, -12, 0, 0, 0] 
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This physiologic-oscillatory waveform is similar to the physiologic wave for with respect 
to shape and maximum flow.  Note the minimum flow rate of -.41 ml/min and the mean 
flow of .79 ml/min 
 
Figure 17 - High flow waveform at 5 Hz with profile [14, -9, 0, 0, 0] 
The high flow waveform has maximum flow of 3.26 ml/min, a minimum flow of .67 
ml/min and mean flow of 1.71 ml/min.  At 5 Hz we begin to see the breakdown of the 
1/3-2/3 pulsatile flow profile seen in the mouse.  The profile here begins to look more 
sinusoidal when compare with a physiologic 1 Hz frequency or in-vivo profile, which 
reduces flow rates and in turn shear rates on endothelial cells.  
 36
 
Figure 18 - Low-oscillatory flow waveform at 5 Hz with profile [5, -3.75, 0, 0] 
The low–oscillatory flow waveform has a maximum flow of .79 ml/min and minimum 
flow of -.4 ml/min which gives the waveform its oscillatory component.  The mean flow 




Figure 19 - Sinusoidal flow waveform at 5 Hz with profile [1, 7.5, 1, -5, -0.1] 
The sinusoidal waveform at 5 Hz has a maximum flow of 2.7 ml/min and a minimum 
flow of 1.1 ml/min.  Notice the lower flow rates that result from the sinusoidal waveform 
as compared to a physiologic waveform.   
 
At 10 Hz the system was able to produce physiologic, physiologic-oscillatory, high flow, 
low-oscillatory, low, and sinusoidal waveforms at a steady pressure of 100mmhg. 
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Figure 20 - Physiologic waveform at 10 Hz with profile [11, -6, -0.5, 0, 0] 
The physiologic waveform at 10 Hz has a max flow of 1.87 ml/min and a minimum flow 
of .25 ml min with a mean flow of .98 ml/min.  Notice that at this higher frequency the 




Figure 21 - Physiologic oscillatory waveform at 10 Hz with profile [15, -12, 0, 0, 0] 
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The physiologic-oscillatory waveform at 10 Hz has a maximum flow of 1.9 ml/min and a 
minimum flow of -.64 ml/min and a mean flow rate of .6 ml/min.  Oscillating flow at this 
higher frequency appears to cause a more sinusoidal waveform, resulting in lower flow 
rates and in turn lower shear rates.   
 
 
Figure 22 – Low-oscillatory flow waveform at 10 Hz with profile [8.5--6—0] 
The low-oscillatory wave for has mean flow of .32 ml/min, a maximum flow of 1.34 
ml/min, and a minimum flow of -.45 ml/min that gives the waveform its oscillatory 
component.  Note the increased noise at the in the +/- .5 ml/min range.  The sinusoidal 
affects on the waveform continue as seem with other oscillatory flows at this frequency.  
This noise effects result in lower flow-rates and in turn lower shear rates.  
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Figure 23 - Low flow waveform at 10 Hz with profile [7.5, -4.5, 0] 
The low flow waveform at 10 Hz has a maximum flow rate of .94 ml/min, minimum flow 
rate of .07 ml/min, and a mean flow rate of .44 ml/min.  Note that waveform has 
increased noise between .5 ml/min and 0 ml/min.  Additionally the shape of the 
waveform resembles more of a saw tooth with the higher flow rates and corresponding 
shear rates that occur with physiologic flow at 10 Hz. 
 
Shear stresses were calculated using the following estimation of wall shear stress. 
  32/	
 
Media with a viscosity of 1 cP was utilizes during the characterization of the system.  In 
order to demonstrates the system’s ability to perform with more viscous solution Dextran 
(6.5%) was added to the media to increase the viscosity to 4.2 cP which increases the 
wall shear stresses.  The in-vivo shear stress on mouse carotid arteries is approximately 
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12 dynes/s.  The 5 Hz and 10 Hz physiologic groups most closely achieve that shear level 
(~8 to 9.5 dynes/s).  Shear levels for the all other groups are consistent between the 5 Hz 
and 10 Hz groups.  Shear stress can be modulated in the future either by changing the 
viscosity, i.e. amount of Dextran, or the waveform.  
 





Both the control vessel and cultured vessel turned purple after exposure to the 
MTT assay (Figure 22).  However the cultured vessel was noticeably purple in the lumen 
of the vessel (Figure 22B) while the control vessel that was noticeably purple in lumen 
and adventitia (Figure 22A).  Both arteries were segmented before introduction into the 
MTT assay however only one segment was analyzed from the experimental group as 
suture segments adhered to the remainder of the vessel, causing those segments to appear 
darker and purple.      
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Figure 25 - A) Control vessel freshly isolated and exposed to MTT.  B)  Vessel after 6 hours of culture 




After 6 hours of culture under physiologic waveform at 10 Hz the addition of PE 
(10-5M) did not result in vessel constriction within 20 minutes.  The addition of ACh (10-
5) did not result in vessel dilation or constriction after 20 minutes and the addition of SNP 




Nitric Oxide Production 
NO release was measured while culturing the vessel with a 10 Hz physiologic 
waveform.  The results are shown in figure 22.  The vessel is held at static flow time 50s 
when media begins to flow through the vessel at physiologic conditions.  NO release 
peaks at 100s and appears to reach its steady state 225s; however small local peak occur 
in NO while at steady state.  This is most likely due to the zero flow that occurs while the 
motor transitions from one direction to the other; the NO level appears to return to its 





Figure 26 - This figure shows the concentration of NO measure distal to the vessel.  The vessel is 
cultured under static conditions.  At 50 s, where the sharp peak is observed, physiologic culture was 
started at 10 Hz.  This is followed by a precipitous increase in NO concentration until 100 s when the 
NO concentration decreases until it stabilizes at approximately 705 nM.  Flow is terminated at 675 s   
Reactive Oxygen Species Production 
Increased expression of ROS is clearly evident in the positive control group; 
vessels treated with LPS, as compared to the freshly isolated group.  Differences in ROS 
expression were not evident when comparing images of a vessel cultured at low flow 
with one cultured at physiologic flow. Additionally differences in ROS expression were 





Figure 27 - Images of same carotid artery after 6 hour culture 
while mounted on device.  A)  Before introduction of HCy3 ROS 
probe B) After introduction of HCy3 ROS probe.  After 
introducing the probe into the lumen of the vessel no significant 






With this study we were able to show the devices capability to modulate the shape 
of the waveform by changing the max flow, minimum flow, directions of flow, or shape 
of flow profile at various frequencies.  However this ability diminishes as frequency 
increases.  This resulted in more sinusoidal waveforms that don’t produce the higher 
shear rates of physiologic waveforms.   Additionally we were able to monitor diameter, 
flow, pressure, NO in real-time, and possibly ROS if expression techniques can be 
developed to image for HCy3 without having to fix cells.  This device is able to test 
acute, intermediate, and long term effect on remodeling and morphogenesis of changes to 
any global or local parameter that is flow depending(mean flow, max flow, oscillatory 
flow, flow rate, shear stress).  This includes short term culture (6 hours), intermediate 
culture (1-2 days), and long term culture (1-2 weeks)   
System performance was excellent with no seizing of the motor or contamination 
within the 6 hour culture.  Occasionally distilled water was dropped on the syringe shafts 
during testing to increase lubrication within the syringe.  
Flow rates in the range of +/- . 5ml/min were difficult to quantify because of 
electrical noise in the system.  This was especially apparent when placing the entire 
system within the incubator.  All experiment were conducted using DMEM with have 
approximately 1/3 the viscosity of blood.  In order to test any hypothesis using oscillatory 
waveforms it is recommended that the viscosity remain low so as to decrease the shear 
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stress.  This allows for the use of higher flow to achieve desired in-vivo shear rate and 
avoid the noise complications and compressibility issues seen at low oscillating flow 
rates of the system.  De-gassing the liquid used may allow for accurate measurements of 
flow in the +/- 5 ml/min range as the fluid would become more incompressible resulting 
in a quicker response to changes in direction.  
During functional testing the mitochondrial activity was evident in both the control 
and experimental vessel.  The experimental vessel only showed evidence of 
mitochondrial activity in the lumen suggesting that cells in the adventitia and the outside 
of the vessel had died while endothelial and smooth muscle cells remained viable.  
Functional testing of endothelial and smooth muscle cell functionality was not successful 
despite the presence of mitochondrial activity in those areas.  Functional testing has 
worked previously on the device under less physiologic flow conditions therefore it is 
unclear why the SMCs and EC did not respond to their respective stimuli.    
The acute NO release during short no flow changes is an interesting phenomena.  
That requires further investigation.  Because of NO’s atheroprotective nature it would be 
expected to have higher concentration at higher flows, not lower flows.  Additional the 
NO concentration levels were testes after depressurizing the vessel because the using the 
probe under pressure without clamping down on the probe body caused media to leak 
inside the probe causing it read it maximum value.   
We were able to see increase in ROS expression when using a positive control.  
Unfortunately now significant differences in fluorescence were visible after culture with 
low flow compared to physiologic flow. Refinements in confocal microscopy techniques 
may be necessary in order to track these differences in ROS expression.  Additionally 
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opening up the vessel en face may give a better window to look at the cells and determine 
ROS expression.  However this method would prevent the observation of real-time 
production of ROS which can be accomplished via mounting the Living Systems device 
on the confocal microscopy while culturing with media infused with HCy3.   
 
Limitations and Future Work 
With the current set-up the pulse pressure remains static during culture.  The addition 
of a second linear motor in series with the pressure transducers as seen below in figure 28 
should give the system the ability to impose pulse pressure of different magnitudes as 
well as vary the timing of the pulse pressures.  This allows for the pulse pressure to be in 
or out of face with the pulsatile flow. 
In order to accomplish longer cultures of 1 to 2 weeks, an enclosure may be 
necessary for the motor and syringes in order to prevent contamination of the media via 
the syringe shafts that are open to the air during their draw cycle. 
A more exhaustive analysis of the flow conditions near the wall would be necessary 
to determine more accurately shear stresses acting near the wall on the endothelial cells.  
This could be achieved using and oscillatory index or other numerical analysis[8]. 
A system that uses Fourier series to fit the flow waveform produced to a desired flow 
waveform would significantly reduce the time currently required to do this iteration 
manually.  With the current system the operator must read each waveform from the flow 
data of the ultrasound probe and make adjustment manually to the motor motion to try 
and fit the actual curve to the desired curve.  The development of each curve can take 
upwards of two hours. 
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CHAPTER 5:  CONCLUSIONS  
A novel device was developed to study the effects of a wide range of flow 
conditions on extracted mouse carotid arteries.  A number of designs were considered 
with the final design incorporating a computer controlled linear motor that drives two 
syringes in opposite direction with two computer controlled valve that assures forward 
flow through the vessel.  Additionally the device integrated a camera, pressure 
transducers, and flow meter in order to monitor this information in real-time.  All 
electromechanical parts of the system were integrated using a comprehensive Labview 
code.   
The device was successful at producing physiologic, high, low, low-oscillatory, 
sinusoidal flow waveforms at frequencies ranging from 1 to 10 Hz; additionally the 
device it able to produce these waveforms at very low flows, +/- 3 ml/min.  Shear stresses 
experienced by endothelial cells on the vessel mounted in the system can be modulated 
either by changing the viscosity of the liquid or changing the waveform of the flow 
through the vesse 
Real-time NO detection was successfully integrated into the system via use a 
computer integrated probe.  Changes in NO release were detected when changing to flow 
from static conditions to physiologic and vice versa.  ROS detection wproved more 
difficult as no discernable difference was seen between the vessels cultured under low 
flow conditions and physiologic flow conditions.  However improved confocal 
microscopy techniques may reveal more discernable results.  
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APPENDIX A: MATLAB CODE TO DISCRETIZE FLOW 
clear 
clc 
freq = input('What Frequency (Hz) ') 
points = input('How many discretized points of the flow profile ') 
dt = (1/freq)/points; 
  
draw_length = 58.9;  %in mm 
draw_volume = 1.0; % in mL 
conversion = (1/60)*(draw_length/draw_volume); %conversion of mL/min to 
mm/s 
max_length = 20; % longest travel possible without causing a fault 
30max 
  
%enter flow profile points 
title_prof ='' 
for i=1:points 
flow_prof(i) = input('Enter point value ') 
title_prof = strcat(title_prof,num2str(flow_prof(i)),'-') 
end 
  
%make flow profile into string 
  
%initial conditions 
time(1) = 0; 
int_flow(1) = 0; 
i = 2; 
count = 1; 
xposition(1) = 0; 
  
flow_prof(points+1) = flow_prof(1); 
  
%forward movement 
while max(xposition) < max_length 
    time(i) = time(i-1) + dt; 
    int_flow(i) = ((flow_prof(count) + flow_prof(count+1))/2) * dt * 
conversion; 
    xposition(i) = (int_flow(i) + xposition(i-1)); 
    if count == points 
        count = 1; 
    else 
        count = count + 1; 
    end 




while min(xposition) >= -1 
    time(i) = time(i-1) + dt; 
    int_flow(i) = ((flow_prof(count) + flow_prof(count+1))/2) * dt * 
conversion; 
    xposition(i) = (xposition(i-1) - int_flow(i)); 
    if count == points 
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        count = 1; 
    else 
        count = count + 1; 
    end 
       i = i + 1; 
end 
fp = fopen(sprintf('Frequency=%d(Hz)_Points=%d_Profile=%s', freq, 
points, title_prof), 'w'); 
  
for i=1:length(xposition) 












Start_Path = 'C:\Documents and Settings\Lab\My Documents\Seth\flow 
data\*.*'; 




flow_data = load(file); 
  
%determine time increment 
raw_time = flow_data(:,1); 
count = 0; 
start = 0; 
status = 0; 
  
%determine when time starts 
for i=1:length(raw_time)-1 
    while (status == 0)&& (raw_time(i+1,1)~= raw_time(i,1)) 
        start = i; 
        status = 1; 
    end 
end 
  
%determine when time stops 
status2 = 0; 
stop = 0; 
for i=start+1:length(raw_time)-1 
    while (status2 == 0)&& (raw_time(i+1,1)~= raw_time(i,1)) 
        stop = i; 
        status2 = 1; 
    end 
end 
  
%construct time array 
time_inc = 1/(stop-start); 
time = linspace (0,length(raw_time),length(raw_time))*time_inc; 
time = time'; 
  
%process flow data 
raw_flow = flow_data(:,2); 
proc_flow = (raw_flow*2.5)/(1000); 
  
all_data = [time proc_flow]; 
  
  










% %determine mean flow rate 
% start_flow = input('When does flow begin?'); 
% stop_flow = input ('When does flow cease?'); 
%  
%  
% proc_flow_trimmed = 
proc_flow((start_flow/time_inc):(stop_flow/time_inc) 




         
     




















1. WRITING GROUP MEMBERS, et al., Heart Disease and Stroke Statistics--2009 
Update: A Report From the American Heart Association Statistics Committee and 
Stroke Statistics Subcommittee. Circulation, 2009. 119(3): p. e21-181. 
 
2. Humphrey, J.D., ed. Cardiovascular Solid Mechanics: Cells, Tissues, and 
Organs. 2002, Springer: New York. 
 
3. Ku, D.N., BLOOD FLOW IN ARTERIES. Annual Review of Fluid Mechanics, 
1997. 29(1): p. 399-434. 
 
4. Matsumoto, T. and K. Hayashi, Stress and Strain Distribution in Hypertensive 
and Normotensive Rat Aorta Considering Residual Strain. Journal of 
Biomechanical Engineering, 1996. 118(1): p. 62-73. 
 
5. Kamiya, A. and T. Togawa, Adaptive regulation of wall shear stress to flow 
change in the canine carotid artery. Am J Physiol Heart Circ Physiol, 1980. 
239(1): p. H14-21. 
 
6. Jackson, Z.S., A.I. Gotlieb, and B.L. Langille, Wall Tissue Remodeling Regulates 
Longitudinal Tension in Arteries. Circ Res, 2002. 90(8): p. 918-925. 
 
7. Masuda, H., et al., Adaptive Remodeling of Internal Elastic Lamina and 
Endothelial Lining During Flow-Induced Arterial Enlargement. Arterioscler 
Thromb Vasc Biol, 1999. 19(10): p. 2298-2307. 
 
8. Ku, D., et al., Pulsatile flow and atherosclerosis in the human carotid bifurcation. 
Positive correlation between plaque location and low oscillating shear stress. 
Arterioscler Thromb Vasc Biol, 1985. 5(3): p. 293-302. 
 
9. Zarins, C., et al., Carotid bifurcation atherosclerosis. Quantitative correlation of 
plaque localization with flow velocity profiles and wall shear stress. Circ Res, 
1983. 53(4): p. 502-514. 
 
10. Giddens, D.P., C.K. Zarins, and S. Glagov, The Role of Fluid Mechanics in the 
Localization and Detection of Atherosclerosis. Journal of Biomechanical 
Engineering, 1993. 115(4B): p. 588-594. 
 
11. Vinay Kumar, A.K.A., Nelson Fausto and Richard Mitchell, ROBBINS BASIC 
PATHOLOGY. 7 Sub edition ed. Vol. . 2007: W.B. Saunders Company. 960. 
 
12. Griendling, K.K., D. Sorescu, and M. Ushio-Fukai, NAD(P)H Oxidase : Role in 
Cardiovascular Biology and Disease. Circ Res, 2000. 86(5): p. 494-501. 
 57
 
13. Forstermann, U. and T. Munzel, Endothelial Nitric Oxide Synthase in Vascular 
Disease: From Marvel to Menace. Circulation, 2006. 113(13): p. 1708-1714. 
 
14. Forstermann, U., et al., Nitric oxide synthase isozymes. Characterization, 
purification, molecular cloning, and functions. Hypertension, 1994. 23(6): p. 
1121-1131. 
 
15. Abilez, O., et al., A Novel Culture System Shows that Stem Cells Can be Grown in 
3D and Under Physiologic Pulsatile Conditions for Tissue Engineering of 
Vascular Grafts. Journal of Surgical Research, 2006. 132(2): p. 170-178. 
 
16. Gleason, R.L., et al., A Multiaxial Computer-Controlled Organ Culture and 
Biomechanical Device for Mouse Carotid Arteries. Journal of Biomechanical 
Engineering, 2004. 126(6): p. 787-795. 
 
17. Peng, X., et al., In vitro system to study realistic pulsatile flow and stretch 
signaling in cultured vascular cells. Am J Physiol Cell Physiol, 2000. 279(3): p. 
C797-805. 
 
18. James E. Moore Jr. Contact Information, E.B., Andreas Suciu, Shumin Zhao, 
Michel Burnier, Hans R. Brunner and Jean-Jacques Meister, A device for 
subjecting vascular endothelial cells to both fluid shear stress and circumferential 
cyclic stretch. Annals of Biomedical Engineering, 1994. 22(4): p. 6. 
 
19. Janssen, B.J.A., P.J.A. Leenders, and J.F.M. Smits, Short-term and long-term 
blood pressure and heart rate variability in the mouse. Am J Physiol Regul Integr 
Comp Physiol, 2000. 278(1): p. R215-225. 
 
20. Conway, D.E., et al., Expression of CYP1A1 and CYP1B1 in human endothelial 
cells: regulation by fluid shear stress. Cardiovasc Res, 2009. 81(4): p. 669-677. 
 
21. Kousik Kundu, et al., Hydrocyanines: A Class of Fluorescent Sensors That Can 
Image Reactive Oxygen Species in Cell Culture, Tissue, and In Vivo13. 
Angewandte Chemie International Edition, 2009. 48(2): p. 299-303. 
 
22. Transonic Systems, I., Tools and Techniques for Hemodynamic Studies in Mice 
    Available at http://www.transonic.com., 1997. 
 
